Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 918
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase1, Recruiting
Ultrasound for Quantifying Muscle Activation Elicited by Spinal Cord Stimulation and Functional Electrical Stimulation
for
Neuromodulatory Effects of TSCS and FES in Lower Limbs
Location: Raleigh NC
Sponsor: North Carolina State University
Sex: All
Age: 18 - 60
Code: NCT07206797
Recruiting
Outpatient Epcoritamab in Large B-cell Lymphoma
for
Relapsed Large B-cell Lymphoma,
Location: Boston MA, Newton MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06811272
Phase2, Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07204340
Phase1, Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: Halifax, New Haven CT, Quebec, Chicoutimi, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06549595
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
for
Lymphoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05294367
Early_phase1, Recruiting
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
for
Richter Syndrome, Diffuse Large B-Cell Lymphoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT06863402
Phase2, Recruiting
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
for
T-cell Acute Lymphoblastic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 21
Code: NCT06561074
Phase2, Recruiting
Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (SLL)
Location: Boston MA, New York NY
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06849713
Phase2, Recruiting
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Chicago IL
Sponsor: Reem Karmali
Sex: All
Age: 18+
Code: NCT06723457
Phase2, Recruiting
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
for
Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07014293
Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase2, Recruiting
Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
for
Lymphoid, Hodgkin Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07444632
Phase1, Recruiting
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
for
Recurrent Atypical Teratoid/Rhabdoid Tumor,
Location: San Francisco CA
Sponsor: Sabine Mueller, MD, PhD
Sex: All
Age: 1 - 39
Code: NCT07447076
Phase2, Recruiting
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
for
Leukemia, Lymphoma, Hematologic Malignancy
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06856226
Recruiting
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia